van de Winkel JG - Search Results

1

Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies.

Stockmeyer B, Elsässer D, Dechant M, Repp R, Gramatzki M, Glennie MJ, van de Winkel JG, Valerius T. Stockmeyer B, et al. Among authors: van de winkel jg. J Immunol Methods. 2001 Feb 1;248(1-2):103-11. doi: 10.1016/s0022-1759(00)00346-x. J Immunol Methods. 2001. PMID: 11223072

2

Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.

Repp R, Kellner C, Muskulus A, Staudinger M, Nodehi SM, Glorius P, Akramiene D, Dechant M, Fey GH, van Berkel PH, van de Winkel JG, Parren PW, Valerius T, Gramatzki M, Peipp M. Repp R, et al. Among authors: van berkel ph, van de winkel jg. J Immunol Methods. 2011 Oct 28;373(1-2):67-78. doi: 10.1016/j.jim.2011.08.003. Epub 2011 Aug 9. J Immunol Methods. 2011. PMID: 21855548

3

Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing.

Dechant M, Vidarsson G, Stockmeyer B, Repp R, Glennie MJ, Gramatzki M, van De Winkel JG, Valerius T. Dechant M, et al. Among authors: van de winkel jg. Blood. 2002 Dec 15;100(13):4574-80. doi: 10.1182/blood-2002-03-0687. Epub 2002 Aug 8. Blood. 2002. PMID: 12393717 Free article.

4

Epidermal growth factor receptor and g250: useful target antigens for antibody mediated cellular cytotoxicity against renal cell carcinoma?

Stadick H, Stockmeyer B, Kühn R, Schrott KM, Kalden JR, Glennie MJ, van de Winkel JG, Gramatzki M, Valerius T, Elsässer D. Stadick H, et al. Among authors: van de winkel jg. J Urol. 2002 Feb;167(2 Pt 1):707-12. doi: 10.1016/S0022-5347(01)69131-6. J Urol. 2002. PMID: 11792958

5

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.

Repp R, van Ojik HH, Valerius T, Groenewegen G, Wieland G, Oetzel C, Stockmeyer B, Becker W, Eisenhut M, Steininger H, Deo YM, Blijham GH, Kalden JR, van de Winkel JG, Gramatzki M. Repp R, et al. Among authors: van ojik hh, van de winkel jg. Br J Cancer. 2003 Dec 15;89(12):2234-43. doi: 10.1038/sj.bjc.6601367. Br J Cancer. 2003. PMID: 14676800 Free PMC article. Clinical Trial.

6

Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy.

Valerius T, Repp R, de Wit TP, Berthold S, Platzer E, Kalden JR, Gramatzki M, van de Winkel JG. Valerius T, et al. Among authors: de wit tp, van de winkel jg. Blood. 1993 Aug 1;82(3):931-9. Blood. 1993. PMID: 7687898 Free article.

7

G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).

Repp R, Valerius T, Wieland G, Becker W, Steininger H, Deo Y, Helm G, Gramatzki M, Van de Winkel JG, Lang N, et al. Repp R, et al. Among authors: van de winkel jg. J Hematother. 1995 Oct;4(5):415-21. doi: 10.1089/scd.1.1995.4.415. J Hematother. 1995. PMID: 8581378 Review.

8

HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor.

Elsässer D, Valerius T, Repp R, Weiner GJ, Deo Y, Kalden JR, van de Winkel JG, Stevenson GT, Glennie MJ, Gramatzki M. Elsässer D, et al. Among authors: van de winkel jg. Blood. 1996 May 1;87(9):3803-12. Blood. 1996. PMID: 8611706 Free article.

9

Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer.

Stockmeyer B, Valerius T, Repp R, Heijnen IA, Bühring HJ, Deo YM, Kalden JR, Gramatzki M, van de Winkel JG. Stockmeyer B, et al. Among authors: van de winkel jg. Cancer Res. 1997 Feb 15;57(4):696-701. Cancer Res. 1997. PMID: 9044847

10

HLA class II antibodies recruit G-CSF activated neutrophils for treatment of B cell malignancies.

Valerius T, Elsässer D, Repp R, Van de Winkel JG, Gramatzki M, Glennie M. Valerius T, et al. Among authors: van de winkel jg. Leuk Lymphoma. 1997 Jul;26(3-4):261-9. doi: 10.3109/10428199709051775. Leuk Lymphoma. 1997. PMID: 9322888 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters